A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer’s disease.
New compound targets the neuronal epigenome to treat Alzheimer’s disease
- Post author:admin
- Post published:
- Post category:uncategorized